BPC-157 is also known as the Wolverine peptide, for its supportive role with repair and recovery, many have also found that its helped support gut issues, gastric reflux, depression, performance, and more
Thursdays vote moved it one step further along an uncertain regulatory process but the outcome of that process is still well over a year away.
Semaglutide and tirzepatide are GLP-1 receptor agonists (tirzepatide also targeting GIP), mimicking gut hormones that regulate satiety and blood sugar a well-established pathway with extensive human data
Understanding how reconstitution differs between these peptides prevents the most common calculation errors researchers make when transitioning protocols
However, it is not a replacement for: Calorie control Resistance training Protein optimization Sleep regulation In controlled studies, fat loss was moderate, not extreme